Royce Smaller-Companies Growth Fund Service Class (RYVPX)

8.04
Net Asset Value
+0.12%
1 Day
+20.18%
Year-to-Date
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
1.52%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund's investment adviser invests the fund's assets primarily in equity securities of companies with stock market capitalizations up to $7.5 billion that Royce believes have above-average growth prospects. Normally, the fund invests at least 80% of its net assets in equity securities of companies with stock market capitalizations up to $7.5 billion. Although the fund normally focuses on securities of U.S. companies, it may invest up to 25% of its net assets (measured at the time of investment) in securities of companies headquartered in foreign countries.

Performance

1 month+2.55% 3 years+7.45%
3 months+4.69% 5 years+7.07%
1 year+13.52% Since inception+10.69%
Data through --

Peer Comparisonvs. Small growth

 RYVPXCategory
Performance 5-yr return+7.07%+9.63%
Expense ratio1.52%1.24%
Risk 5 year sharpe ratio0.420.60
Net assets$262.8M$1.2B
Average market cap$1.4B$3.8B
Average P/E30.627.8
Portfolio turnover61%61%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyRoyce
Fund manager & tenureJames (Chip) Skinner / 15 Years
Minimal initial investment$2,000.00
Minimum IRA investment$1,000.00

Holdings

U.S. stock88.43%
International stock6.78%
Cash4.79%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Industrial materials 20.73%
Financial service 18.96%
Hardware 14.48%
Business service 11.16%
Consumer service 10.62%
Top 10 Holdings
Portfolio weighting
ITI Iteris Inc3.60%
PCTY Paylocity Holding Corp3.42%
USAT USA Technologies Inc2.34%
CHCT Community Healthcare Trust Inc2.22%
MYGN Myriad Genetics Inc2.13%
UIS Unisys Corp2.00%
GPX GP Strategies Corp1.99%
MTLS Materialise NV1.95%
CYRX Cryoport Inc1.69%
WST West Pharmaceutical Services Inc1.60%